1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for Study
1.2.3.
Key Market Segmentations
2.
Research Methodology
2.1.
Objective of
the Study
2.2.
Baseline
Methodology
2.3.
Key Industry
Partners
2.4.
Major
Association and Secondary Sources
2.5.
Forecasting
Methodology
2.6.
Data
Triangulation & Validation
2.7.
Assumptions
and Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Synthetic
Hormones Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Product (Amino Acid Derivatives, Peptide Hormone, Steroid Hormones)
5.2.2.
By Route of Administration (Intravenous, Nasal, Oral, Suppository,
Topical)
5.2.3.
By Application (Growth Hormone Deficiency, Male Hypogonadism, Menopause,
Thyroid Hormone Deficiency)
5.2.4.
By End User (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies)
5.2.5.
By Region
5.2.6.
By Company (2022)
5.3.
Market Map
6. Asia Pacific Synthetic
Hormones Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Product
6.2.2.
By Route of Administration
6.2.3.
By Application
6.2.4.
By End User
6.2.5.
By Country
6.3.
Asia Pacific: Country Analysis
6.3.1.
China Synthetic Hormones Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Route of Administration
6.3.1.2.3.
By Application
6.3.1.2.4.
By End User
6.3.2.
India Synthetic Hormones Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Route of Administration
6.3.2.2.3.
By Application
6.3.2.2.4.
By End User
6.3.3.
Australia Synthetic Hormones Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Route of Administration
6.3.3.2.3.
By Application
6.3.3.2.4.
By End User
6.3.4.
Japan Synthetic Hormones Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Product
6.3.4.2.2.
By Route of Administration
6.3.4.2.3.
By Application
6.3.4.2.4.
By End User
6.3.5.
South Korea Synthetic Hormones Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Product
6.3.5.2.2.
By Route of Administration
6.3.5.2.3.
By Application
6.3.5.2.4.
By End User
7. Europe Synthetic
Hormones Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Product
7.2.2.
By Route of Administration
7.2.3.
By Application
7.2.4.
By End User
7.2.5.
By Country
7.3.
Europe: Country Analysis
7.3.1.
France Synthetic Hormones Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Route of Administration
7.3.1.2.3.
By Application
7.3.1.2.4.
By End User
7.3.2.
Germany Synthetic Hormones Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Route of Administration
7.3.2.2.3.
By Application
7.3.2.2.4.
By End User
7.3.3.
Spain Synthetic Hormones Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Route of Administration
7.3.3.2.3.
By Application
7.3.3.2.4.
By End User
7.3.4.
Italy Synthetic Hormones Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Route of Administration
7.3.4.2.3.
By Application
7.3.4.2.4.
By End User
7.3.5.
United Kingdom Synthetic Hormones Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Route of Administration
7.3.5.2.3.
By Application
7.3.5.2.4.
By End User
8. North America Synthetic
Hormones Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Product
8.2.2.
By Route of Administration
8.2.3.
By Application
8.2.4.
By End User
8.2.5.
By Country
8.3.
North America: Country Analysis
8.3.1.
United States Synthetic Hormones Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Route of Administration
8.3.1.2.3.
By Application
8.3.1.2.4.
By End User
8.3.2.
Mexico Synthetic Hormones Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Route of Administration
8.3.2.2.3.
By Application
8.3.2.2.4.
By End User
8.3.3.
Canada Synthetic Hormones Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Route of Administration
8.3.3.2.3.
By Application
8.3.3.2.4.
By End User
9. South America Synthetic
Hormones Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Product
9.2.2.
By Route of Administration
9.2.3.
By Application
9.2.4.
By End User
9.2.5.
By Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Synthetic Hormones Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Route of Administration
9.3.1.2.3.
By Application
9.3.1.2.4.
By End User
9.3.2.
Argentina Synthetic Hormones Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Route of Administration
9.3.2.2.3.
By Application
9.3.2.2.4.
By End User
9.3.3.
Colombia Synthetic Hormones Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Route of Administration
9.3.3.2.3.
By Application
9.3.3.2.4.
By End User
10. Middle East and Africa
Synthetic Hormones Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1. By Product
10.2.2. By Route of Administration
10.2.3. By Application
10.2.4. By End User
10.2.5.
By Country
10.3.
MEA: Country Analysis
10.3.1.
South Africa Synthetic Hormones Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Route of Administration
10.3.1.2.3.
By Application
10.3.1.2.4.
By End User
10.3.2.
Saudi Arabia Synthetic Hormones Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Route of Administration
10.3.2.2.3.
By Application
10.3.2.2.4.
By End User
10.3.3.
UAE Synthetic Hormones Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Route of Administration
10.3.3.2.3.
By Application
10.3.3.2.4.
By End User
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers & Acquisitions
13.
Global Synthetic Hormones Market: SWOT Analysis
14. Porter’s Five Forces
Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Product
15.
PESTLE Analysis
16.
Competitive Landscape
16.1.
Acerus Pharmaceuticals
Corp.
16.1.1.
Business Overview
16.1.2.
Company Snapshot
16.1.3.
Products & Services
16.1.4.
Financials (In case of listed companies)
16.1.5.
Recent Developments
16.1.6.
SWOT Analysis
16.2.
American Regent,
Inc.
16.2.1.
Business Overview
16.2.2.
Company Snapshot
16.2.3.
Products & Services
16.2.4.
Financials (In case of listed companies)
16.2.5.
Recent Developments
16.2.6.
SWOT Analysis
16.3.
Anhui Anke
Biotechnology (Group) Co. Ltd.
16.3.1.
Business Overview
16.3.2.
Company Snapshot
16.3.3.
Products & Services
16.3.4.
Financials (In case of listed companies)
16.3.5.
Recent Developments
16.3.6.
SWOT Analysis
16.4. BioPartners, Inc.
16.4.1.
Business Overview
16.4.2.
Company Snapshot
16.4.3.
Products & Services
16.4.4.
Financials (In case of listed companies)
16.4.5.
Recent Developments
16.4.6.
SWOT Analysis
16.5. Eli Lilly and Company
16.5.1.
Business Overview
16.5.2.
Company Snapshot
16.5.3.
Products & Services
16.5.4.
Financials (In case of listed companies)
16.5.5.
Recent Developments
16.5.6.
SWOT Analysis
16.6.
Endo
Pharmaceuticals, Inc.
16.6.1.
Business Overview
16.6.2.
Company Snapshot
16.6.3.
Products & Services
16.6.4.
Financials (In case of listed companies)
16.6.5.
Recent Developments
16.6.6.
SWOT Analysis
16.7.
F. Hoffmann-La Roche
Ltd.
16.7.1.
Business Overview
16.7.2.
Company Snapshot
16.7.3.
Products & Services
16.7.4.
Financials (In case of listed companies)
16.7.5.
Recent Developments
16.7.6.
SWOT Analysis
16.8.
IBSA Institute Biochimique SA
16.8.1.
Business Overview
16.8.2.
Company Snapshot
16.8.3.
Products & Services
16.8.4.
Financials (In case of listed companies)
16.8.5.
Recent Developments
16.8.6.
SWOT Analysis
16.9.
Lupin Pharmaceuticals, Inc.
16.9.1.
Business Overview
16.9.2.
Company Snapshot
16.9.3.
Products & Services
16.9.4.
Financials (In case of listed companies)
16.9.5.
Recent Developments
16.9.6.
SWOT Analysis
16.10. Pfizer, Inc.
16.10.1.
Business Overview
16.10.2.
Company Snapshot
16.10.3.
Products & Services
16.10.4.
Financials (In case of listed companies)
16.10.5.
Recent Developments
16.10.6.
SWOT Analysis
17. Strategic Recommendations
18. About Us & Disclaimer